Propofol and PRIS

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

2 posts / 0 new
Log in or register to post comments
Last post
Fri, 07/07/2023 - 15:56
#1
Daniel Kudryashov
Daniel Kudryashov's picture
Offline
Last seen: 3 months 3 days ago
Joined: 07/26/2018 - 19:27
Propofol and PRIS

Recognizing the risk of Propofol-related infusion syndrome (PRIS) with propofol, we are looking to learn what safety measures health systems have implemented around the use of propofol. I would appreciate your responses to the following questions and any additional feedback:

1) Do you limit duration of propofol infusions to 48 hours? If so, how is this accomplished?
2) What is your maximum allowed infusion rate for propofol?
3) Do you require use of adjusted body weight for dosing in obesity?
4) Do you require routine lab monitoring with propofol? If so, who is responsible and which labs (e.g. Trig, LFT, CK, ABG etc.)
5) Any other measures?

Thank you,
Daniel

Tags: 

Top